OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Xiaoya Ding, PhD, is the director of scientific and technical affairs at the cGMP laboratory, PPD, Inc.
A systematic approach facilitates formulation component selection.
Two case studies illustrate a systematic approach.
With the advent of high-resolution mass spectrometers and highly sensitive MS instruments, vaccine characterization has entered a new phase.